By Kuldip K. Ambastha
The stock price of Sotera Health Company (SHC), an integrated global health solutions company, had a loss of -33.3% per share on Monday, September 19, 2022. On the subsequent trading days of the week, three negative daily returns and one positive daily return were seen. Litigation was the primary cause of the four negative daily returns seen during the trading week, since a lawsuit resulted in the amount of $363 million being awarded to a plaintiff on the matter of ethylene oxide (EO) exposure leading to cancer. With this legal ruling having been made against Sotera and two other companies due to EO exposure from a factory in Illinois, several other lawsuits could also be resolved such that Sotera is found liable for significant monetary damages. Various investors and Wall Street equity research analysts have now turned negative on the stock of Sotera.
Keywords – Sotera Health Company, Sotera Health, Sotera, global health, litigation, legal, lawsuit, law, damages, ethylene oxide, EO, cancer, Wall Street, equity research, negative.
Disclosure – The principals and clients of Ambastha Financial LLC have no positions in SHC.
Disclaimer – No recommendations are being made via this post. Past performance is not an indicator of future performance. As an investor, you should do your own research and seek professional advice from a Registered Investment Adviser (RIA). You can lose money by investing in stocks and other instruments. Ambastha Financial LLC does not assume any responsibility (legal or otherwise) for any losses that may occur as a result of actions taken based on this post. All content copyrighted © 2022 – Ambastha Financial LLC.
CONTACT US